These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38609526)
1. The influence of body composition on the response to dynamic stimulation of the endocrine pituitary-testis axis. Abildgaard J; Bang AK; Nordkap L; Priskorn L; Jørgensen N Int J Obes (Lond); 2024 Sep; 48(9):1216-1222. PubMed ID: 38609526 [TBL] [Abstract][Full Text] [Related]
2. Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients. Tokgöz B; Utaş C; Dogukan A; Güven M; Taşkapan H; Oymak O; Keleştimur F Perit Dial Int; 2001; 21(5):448-54. PubMed ID: 11757827 [TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study. Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518 [TBL] [Abstract][Full Text] [Related]
4. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192 [TBL] [Abstract][Full Text] [Related]
5. Dynamic Interactions Between LH and Testosterone in Healthy Community-Dwelling Men: Impact of Age and Body Composition. Roelfsema F; Liu PY; Takahashi PY; Yang RJ; Veldhuis JD J Clin Endocrinol Metab; 2020 Mar; 105(3):e628-41. PubMed ID: 31790144 [TBL] [Abstract][Full Text] [Related]
6. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. Finkelstein JS; Badger TM; O'Dea LS; Spratt DI; Crowley WF J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251 [TBL] [Abstract][Full Text] [Related]
7. [Endocrine profiles and gonadotropin response to Gn-RH of men with testicular cancer]. Watanabe M; Fuji K; Suzuki K; Kitamura T; Okumura D; Kasahara T; Igarashi T; Masuyama T; Hiramori T; Higaki M; Yoshida H Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):543-50. PubMed ID: 12910930 [TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454 [TBL] [Abstract][Full Text] [Related]
9. Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels. Bang AK; Nordkap L; Almstrup K; Priskorn L; Petersen JH; Rajpert-De Meyts E; Andersson AM; Juul A; Jørgensen N Eur J Endocrinol; 2017 Apr; 176(4):379-391. PubMed ID: 28077499 [TBL] [Abstract][Full Text] [Related]
10. Testicular volume and clinical correlates of hypothalamic-pituitary-testicular function: A cross-sectional study in obese men. Tang Fui MN; Hoermann R; Wittert G; Grossmann M Asian J Androl; 2020; 22(4):354-359. PubMed ID: 31535628 [TBL] [Abstract][Full Text] [Related]
11. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290 [TBL] [Abstract][Full Text] [Related]
12. Pituitary-testicular reserve in men with low serum testosterone and normal serum luteinizing hormone. Glass AR J Androl; 1988; 9(3):224-30. PubMed ID: 3136121 [TBL] [Abstract][Full Text] [Related]
13. Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Kauschansky A; Dickerman Z; Phillip M; Weintrob N; Strich D Clin Endocrinol (Oxf); 2002 May; 56(5):603-7. PubMed ID: 12030910 [TBL] [Abstract][Full Text] [Related]
14. Regulation of pituitary gonadotropin-releasing hormone receptors by pulsatile gonadotropin-releasing hormone injections in male rats. Modulation by testosterone. Garcia A; Schiff M; Marshall JC J Clin Invest; 1984 Sep; 74(3):920-8. PubMed ID: 6088587 [TBL] [Abstract][Full Text] [Related]
15. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation. Huhtaniemi IT; Catt KJ Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus. Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162 [TBL] [Abstract][Full Text] [Related]
17. Role of gonadal negative feedback on the gonadotrophin responses to gonadotrophin-releasing hormone (GnRH) in ram lambs from two lines of sheep selected for their luteinizing hormone response to GnRH. Evans NP; Land RB; McNeilly JR; Webb R J Reprod Fertil; 1991 Nov; 93(2):549-58. PubMed ID: 1787476 [TBL] [Abstract][Full Text] [Related]
18. Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial. Zheng J; Mao J; Xu H; Wang X; Huang B; Liu Z; Cui M; Xiong S; Ma W; Min L; Kaiser UB; Nie M; Wu X J Clin Endocrinol Metab; 2017 Jul; 102(7):2291-2300. PubMed ID: 28368486 [TBL] [Abstract][Full Text] [Related]
19. Alteration of the hypothalamus-pituitary-testis axis in oligozoospermic men with normal gonadotropin levels. Fujisawa M; Kanzaki M; Hayashi A; Tanaka H; Okada H; Arakawa S; Kamidono S Int J Urol; 1995 Sep; 2(4):273-6. PubMed ID: 8564748 [TBL] [Abstract][Full Text] [Related]
20. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]